close :

:

Forgotten your password?
 
FDA Drug Approvals
Printable Version   Email to a friend

Boniva IV Approved - Roche/GlaxoSmithKline - Treatment for Postmenopausal Osteoporosis

Boniva Injection is an intravenous formulation of the bisphosphonate drug ibandronate sodium, administered quarterly for the treatment of postmenopausal osteoporosis.

Latest FDA Drug Approvals...

FDA Drug Approvals Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Oct | Dec

More News Resources